Status:
UNKNOWN
The Association of Microbiota Composition With cGVHD After Allo-HSCT
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Conditions:
Hematopoietic Stem Cell Transplantation
Hematologic Malignancy
Eligibility:
All Genders
18-65 years
Brief Summary
Previous studies had found that the microbe in intestinal after allogeneic hematopoietic cell transplantation(allo-HSCT) were closely associated with overall survival and post-transplantation complica...
Detailed Description
Previous studies had found that the microbe in intestinal after allogeneic hematopoietic cell transplantation(allo-HSCT) were closely associated with overall survival and post-transplantation complica...
Eligibility Criteria
Inclusion
- aged between 18 years and 65 years
- patients planned to be treated by allogeneic hematopoietic cell transplantation
- signed written informed consent
Exclusion
- patients not-matching inclusion criteria
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05355675
Start Date
May 1 2022
End Date
May 31 2025
Last Update
August 2 2022
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
The first Affiliated Hospital of Zhejiang University
Hangzhou, Zhejiang, China, 310000
2
First Affiliated Hospital of Zhejiang Chinese Medicine University
Hangzhou, Zhejiang, China
3
Second Affiliated Hospital of Zhejiang University, School of Medicine
Hangzhou, Zhejiang, China
4
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Hangzhou, China